Cargando…
Unveiling the Clinical Benefits of High-Volume Hemodiafiltration: Optimizing the Removal of Medium-Weight Uremic Toxins and Beyond
Dialysis treatment has improved the survival of patients with kidney failure. However, the hospitalization and mortality rates remain alarmingly high, primarily due to incomplete uremic toxin elimination. High-volume hemodiafiltration (HDF) has emerged as a promising approach that significantly impr...
Autores principales: | Pedreros-Rosales, Cristian, Jara, Aquiles, Lorca, Eduardo, Mezzano, Sergio, Pecoits-Filho, Roberto, Herrera, Patricia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535648/ https://www.ncbi.nlm.nih.gov/pubmed/37755957 http://dx.doi.org/10.3390/toxins15090531 |
Ejemplares similares
-
In silico comparison of protein-bound uremic toxin removal by hemodialysis, hemodiafiltration, membrane adsorption, and binding competition
por: Maheshwari, Vaibhav, et al.
Publicado: (2019) -
Interaction of Human Serum Albumin with Uremic Toxins: The Need of New Strategies Aiming at Uremic Toxins Removal
por: Zare, Fahimeh, et al.
Publicado: (2022) -
Variability in Uremic Control during Continuous Venovenous Hemodiafiltration in Trauma Patients
por: Beitland, Sigrid, et al.
Publicado: (2012) -
Expanded Haemodialysis as a Current Strategy to Remove Uremic Toxins
por: Ciceri, Paola, et al.
Publicado: (2021) -
Poor removal of tedizolid during continuous hemodiafiltration: experiments using an in vitro continuous hemodiafiltration model
por: Yoshikawa, Satoshi, et al.
Publicado: (2023)